Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Consumer News Move Over, Ozempic There Might Be A New Weight Loss Drug is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.Search RobinsPost News & Noticias
'Next Ozempic': A new weight loss drug is on its way, aims to deliver 30% weight loss with fewer side effects
Scientists at Tufts University are developing an experimental drug targeting four hormones—GLP-1, GIP, glucagon, and PYY—to achieve significant weight loss with fewer side effects than current GLP-1 ... Read More
Ozempic in a Pill? Clinical Trial Finds Oral Semaglutide Works For Weight Loss
Semaglutide is currently administered through a weekly dose of up to 2.4 milligrams injected into the layer of fat over the stomach, thigh, or the back of the upper arm. Taking a drug in a pill form ... Read More
Half Of Ozempic Weight-Loss Users Drop The Drug Within A Year
MONDAY, Sept. 15, 2025 (HealthDay News) — Half of people who start taking the GLP-1 weight-loss drug Ozempic drop it within a year, a new study says. Read More
Could GLP-1 weight-loss medications like Ozempic become the 'everything drug'?

Dr. Angela Fitch, co-founder and chief medical officer of knownwell, a "weight-inclusive" healthcare company based in Boston, said she would caution against labeling any medication as an "everything ... Read More
Can coffee affect Ozempic for weight loss? What the experts say

Ozempic and Coffee: How Do They Interact? This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. With around 73 percent of Americans enjoying their daily coffee fix, it’s natural to wonder ... Read More
Novo Nordisk to sell weight-loss drug for $499 to eligible customers

Novo Nordisk said on Monday it is offering its diabetes drug Ozempic for $499 per month to eligible cash-paying type 2 diabetes patients in the U.S. The company said in March that it was cutting the ... Read More
'Next Ozempic' aims to deliver 30% weight loss with fewer side effects
Scientists have created a pre-clinical weight loss drug combining GLP-1, GIP, glucagon and peptide YY hormones to match bariatric surgery effectiveness. Read More
Blow Us A Whistle

Comments (Whistles) Designed By Disqus